Doliracetam

Doliracetam
Clinical data
ATC code	none;
Legal status
Legal status	In general: unscheduled;
Identifiers
	IUPAC name 2-(2-oxo-3-phenyl-3H-indol-1-yl)acetamide;
CAS Number	84901-45-1 ;
PubChem CID	208851;
ChemSpider	180958 ;
UNII	N70177JQTB;
ChEMBL	ChEMBL2106519 ;
Chemical and physical data
Formula	C16H14N2O2
Molar mass	266.300 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CC=C(C=C1)C2C3=CC=CC=C3N(C2=O)CC(=O)N;
	InChI InChI=1S/C16H14N2O2/c17-14(19)10-18-13-9-5-4-8-12(13)15(16(18)20)11-6-2-1-3-7-11/h1-9,15H,10H2,(H2,17,19) ; Key:MVZYGLQQNPFARE-UHFFFAOYSA-N ;
	(what is this?) (verify)

Doliracetam is a nootropic drug (cognition enhancer) from the racetam family used in treatment of epilepsy.^[1]^[2]

According to the Hoechst patent title, it has neuroanabolic action.

References

↑ EP 62887, Kuch, Heinz & Kruse, Hansjörg, "Indolinone-2 derivatives, process for their preparation and neuro-anabolic mediums containing them", published 1982-10-20, assigned to Hoechst AG
↑ Fariello RG, Ghelardini C, Di Cesare Mannelli L, Bonanno G, Pittaluga A, Milanese M, Misiano P, Farina C (June 2014). "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain". Neuropharmacology. 81: 85–94. doi:10.1016/j.neuropharm.2014.01.029. PMID 24486381.

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.